Your browser doesn't support javascript.
loading
Spectrum and prognostic relevance of driver gene mutations in acute myeloid leukemia.
Metzeler, Klaus H; Herold, Tobias; Rothenberg-Thurley, Maja; Amler, Susanne; Sauerland, Maria C; Görlich, Dennis; Schneider, Stephanie; Konstandin, Nikola P; Dufour, Annika; Bräundl, Kathrin; Ksienzyk, Bianka; Zellmeier, Evelyn; Hartmann, Luise; Greif, Philipp A; Fiegl, Michael; Subklewe, Marion; Bohlander, Stefan K; Krug, Utz; Faldum, Andreas; Berdel, Wolfgang E; Wörmann, Bernhard; Büchner, Thomas; Hiddemann, Wolfgang; Braess, Jan; Spiekermann, Karsten.
Affiliation
  • Metzeler KH; Laboratory for Leukemia Diagnostics, Department of Internal Medicine III, Ludwig-Maximilans-Universität, Munich, Germany; German Cancer Consortium (DKTK), Heidelberg, Germany; German Cancer Research Center (DKFZ), Heidelberg, Germany;
  • Herold T; Laboratory for Leukemia Diagnostics, Department of Internal Medicine III, Ludwig-Maximilans-Universität, Munich, Germany; German Cancer Consortium (DKTK), Heidelberg, Germany; German Cancer Research Center (DKFZ), Heidelberg, Germany;
  • Rothenberg-Thurley M; Laboratory for Leukemia Diagnostics, Department of Internal Medicine III, Ludwig-Maximilans-Universität, Munich, Germany;
  • Amler S; Institute of Biostatistics and Clinical Research, University of Münster, Münster, Germany;
  • Sauerland MC; Institute of Biostatistics and Clinical Research, University of Münster, Münster, Germany;
  • Görlich D; Institute of Biostatistics and Clinical Research, University of Münster, Münster, Germany;
  • Schneider S; Laboratory for Leukemia Diagnostics, Department of Internal Medicine III, Ludwig-Maximilans-Universität, Munich, Germany;
  • Konstandin NP; Laboratory for Leukemia Diagnostics, Department of Internal Medicine III, Ludwig-Maximilans-Universität, Munich, Germany;
  • Dufour A; Laboratory for Leukemia Diagnostics, Department of Internal Medicine III, Ludwig-Maximilans-Universität, Munich, Germany;
  • Bräundl K; Laboratory for Leukemia Diagnostics, Department of Internal Medicine III, Ludwig-Maximilans-Universität, Munich, Germany; German Cancer Consortium (DKTK), Heidelberg, Germany; German Cancer Research Center (DKFZ), Heidelberg, Germany;
  • Ksienzyk B; Laboratory for Leukemia Diagnostics, Department of Internal Medicine III, Ludwig-Maximilans-Universität, Munich, Germany;
  • Zellmeier E; Laboratory for Leukemia Diagnostics, Department of Internal Medicine III, Ludwig-Maximilans-Universität, Munich, Germany;
  • Hartmann L; Laboratory for Leukemia Diagnostics, Department of Internal Medicine III, Ludwig-Maximilans-Universität, Munich, Germany; German Cancer Consortium (DKTK), Heidelberg, Germany; German Cancer Research Center (DKFZ), Heidelberg, Germany;
  • Greif PA; Laboratory for Leukemia Diagnostics, Department of Internal Medicine III, Ludwig-Maximilans-Universität, Munich, Germany; German Cancer Consortium (DKTK), Heidelberg, Germany; German Cancer Research Center (DKFZ), Heidelberg, Germany;
  • Fiegl M; Laboratory for Leukemia Diagnostics, Department of Internal Medicine III, Ludwig-Maximilans-Universität, Munich, Germany;
  • Subklewe M; Laboratory for Leukemia Diagnostics, Department of Internal Medicine III, Ludwig-Maximilans-Universität, Munich, Germany; German Cancer Consortium (DKTK), Heidelberg, Germany; German Cancer Research Center (DKFZ), Heidelberg, Germany;
  • Bohlander SK; Department of Molecular Medicine and Pathology, University of Auckland, Auckland, New Zealand;
  • Krug U; Department of Internal Medicine 3, Klinikum Leverkusen, Leverkusen, Germany;
  • Faldum A; Institute of Biostatistics and Clinical Research, University of Münster, Münster, Germany;
  • Berdel WE; Department of Medicine A, Hematology and Oncology, University of Münster, Münster, Germany;
  • Wörmann B; Department of Medicine, Hematology, Oncology, Tumor Immunology, Charité-Universitätsmedizin Berlin, Berlin, Germany; and.
  • Büchner T; Department of Medicine A, Hematology and Oncology, University of Münster, Münster, Germany;
  • Hiddemann W; Laboratory for Leukemia Diagnostics, Department of Internal Medicine III, Ludwig-Maximilans-Universität, Munich, Germany; German Cancer Consortium (DKTK), Heidelberg, Germany; German Cancer Research Center (DKFZ), Heidelberg, Germany;
  • Braess J; Department of Oncology and Hematology, Hospital Barmherzige Brüder, Regensburg, Germany.
  • Spiekermann K; Laboratory for Leukemia Diagnostics, Department of Internal Medicine III, Ludwig-Maximilans-Universität, Munich, Germany; German Cancer Consortium (DKTK), Heidelberg, Germany; German Cancer Research Center (DKFZ), Heidelberg, Germany;
Blood ; 128(5): 686-98, 2016 08 04.
Article in En | MEDLINE | ID: mdl-27288520
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Leukemia, Myeloid, Acute / Mutation Type of study: Clinical_trials / Etiology_studies / Prognostic_studies / Risk_factors_studies Limits: Adolescent / Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Blood Year: 2016 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Leukemia, Myeloid, Acute / Mutation Type of study: Clinical_trials / Etiology_studies / Prognostic_studies / Risk_factors_studies Limits: Adolescent / Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Blood Year: 2016 Type: Article